News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Generic Pharmaceutical Association (GPhA) Statement on Reps. Eshoo-Barton Biologics Bill



3/24/2008 6:39:22 PM

Generic Pharmaceutical Association President and CEO Kathleen Jaeger today issued the following statement on the introduction of the “Pathway to Biosimilars Act” (H.R. 5629): “‘The Pathway for Biosimilars Act’ is a pathway to the wrong destination for patients in need of safe and affordable biogenerics. This new bill, at best, is a disappointing distraction that does nothing to advance legislation. At worst, it’s a step backwards that puts brand company profits before patient needs. For a pathway to work, it must ensure patient access. Unfortunately, this new proposal creates a pathway filled with needless roadblocks to access.

Read at press release


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES